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Peritoneal permeability in the rat: Modulation by microfilament-active
agents. A model of peritoneal dialysis in the rat was used to determine
the effects of cytochalasins on ultrastructure and peritoneal perme-
ability to molecules of varying molecular weight. The permeability to
urea, inulin, and plasma albumin were determined after intraperitoneal
administration of cytochalasin B (2 to 10 x 10-6 M) and cytochalasins
D and E (2 x 10-6 M). Cytochalasin B (20 x 10-6 M) increased the
permeability to inulin, urea, and albumin by 30, 60, and 150%, respec-
tively. These effects were, to a large degree, reversible. Cytochalasins
D and £ produced greater increments in permeability for all molecules;
this increase was only partially reversible. Ultrastructure analysis by
scanning electron microscopy revealed extensive development of mem-
brane protuberances (zeiotic knobs) on mesothelial cells exposed to
cytochalasin B. A return to a normal apical cell surface was apparent
although incomplete at 24 hr. Tight junctions were not grossly altered
and major changes in intramembranous junctional strands were not
observed. The major effect of cytochalasins on the cell surface may be
responsible for the increased permeability to urea, predominately a
transcellular probe, Inulin, which follows a paracellular route, was less
affected. Altered protein permeability may be due to the action of
cytochalasin on the exposed capillary endothelium in subdiaphragmatic
areas where the mesothelium is discontinuous.
Perméabilité peritoneale chez le rat: modulation par des agents actifs
sur les microfilaments. Un modèle de dialyse peritonéale chez le rat a été
utilisé pour determiner les effets de cytochalasines sur l'ultrastructure
et Ia permeabilite peritonéale a des molecules de divers poids
moléculaires. La perméabilité a l'uree, a l'inuline, et a l'albumine
plasmatique a été déterminée aprés administration intrapCritonCale de
cytochalasine B (2 a 20 x 10—6 M) et cytochalasines D et E (2 x 10-6
M). La cytochalasine B (20 x 10-6 M) a augmente Ia permeabilitC a
l'inuline, l'urée, et l'albumine de 30, 60, et 150%, respectivement. Ces
effets étaient, pour une large part, réversibles. Les cytochalasines D et
E ont entrainé des élévations supérieures de perméabilité a toutes les
molecules; cette augmentation était seulement partiellement reversible.
IJne analyse de l'ultrastructure par microscope electronique a balayage
a révélé le developpement extensif de protuberances membranaires
(boutons zeiotiques) sur les cellules mésothéliales exposees a la
cytochalasine B. Un retour a une surface cellulaire apicale normale était
apparent, mais incomplet, a 24 hr. Les jonctions serrées n'étaient pas
très altérées, et on n'observait pas de changement important des zones
jonctionnelles intramembranaires. Cet important effet des cytochala-
sines sur Ia surface cellulaire pourrait étre responsable de l'augmenta-
tion de perméabilité a l'urée, un marqueur a predominance transcel-
lulaire. L'inuline, qui suit une voie paracellulaire, était moms affectée.
L'altération de Ia permeabilite aux protéines pourrait être due a l'action
de la cytochalasine sur l'endothélium capillaire expose dans les zones
sous-diaphragmatiques, le mésothélium est discontinu.
renal failure has increased the significance of understanding
how molecules permeate through the peritoneal membrane. The
peritoneal membrane is a complex barrier, and the various
pathways for permeation of molecules during dialysis remain
poorly defined [1]. Augmentation of peritoneal clearances by
use of pharmacologic agents or other maneuvers has become an
important objective.
Attempts to enhance peritoneal permeability to small and
middle size molecules in peritoneal dialysis have so far focused
on the incorporation of vasodilator compounds into the dialy-
sate. These agents may increase peritoneal blood flow and the
effective area for diffusion or convective flow by recruitment of
collapsed capillaries [2—4].
There is increasing interest in the role of the cytoskeleton in
epithelial cells in the control of net transepithelial transport [5].
Evidence especially supports the involvement of the
submembranous microfilament system in regulation of paracel-
lular transport through the tight junction [6]. It is known that
cytochalasins B and D greatly increase the permeability of
capillary walls, permitting widespread exudation of plasma
albumin and globulins into interstitial spaces when administered
intravenously to experimental animals [7—9]. Cytochalasins are
also known to disrupt microfilaments by binding to the growing
ends of polymerizing actin filaments and thereby preventing
augmentation of actin monomer strands [10—12]. We therefore
decided to investigate the effect of cytochalasins on peritoneal
permeability to gain a better understanding of the function and
structure of the transperitoneal pathways utilized by solutes of
varying molecular weight.
Methods
Peritoneal dialysis was performed in 11 male Witar rats
weighing 250 to 400 g. The dialysis procedures were modifica-
tions of those described by Brown et al [31 and Alavi et al t4].
Dialysis technique. Animals were anesthetized by an
intraperitoneal injection (100 mg/kg of body wt) of mactin (BYK
Gulden Konstanz, West Germany) and placed on a heated
animal table. A tracheostomy was performed. Rectal tempera-
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ture was monitored throughout the experiment. To maintain
constant blood levels of 3H-inulin and urea, a half-normal saline
solution containing 4 1sCi/ml of 3H-inuiin with 0.5 mg/mi of
carrier inulin and 50 mg/mi of urea were infused at a rate of 0.8
mllhr into the jugular vein (Razel Pump, Stamford, Connecti-
cut, USA). This solution (300 pi) was given to the rat as a
priming dose immediately before starting the infusion.
Peritoneal dialysis was performed via a shortened, sterile
catheter (McGaw Laboratories, Irvine, California, USA) in-
serted in the peritoneal cavity through a midline incision. To
exclude net water and solute movement as a result of osmotic
gradients created across the peritoneal membrane, an isotonic
Ringer's lactate solution was used as the dialysate. Thirty
minutes following the injection of the priming dose and infu-
sion, several washes of the peritoneal cavity were performed
with the Ringer's solution to remove accumulated 3H-inulin and
urea and to ensure satisfactory drainage. The latter was in-
dicated by a full return (± 1 ml) of the infused dialysate volume
within 3 mm.
Three control cycles were then performed using either 25 or
30 ml of warm (37°C) dialysate, depending on the size of the
animal. Dialysate was infused within 30 sec, remained in the
peritoneal cavity 12 mm, and was allowed to drain for 3 mm.
Thus, the duration of each cycle was considered to be 15 mm.
In the next three cycles, cytochalasins B, D, or E (Aldrich
Chemicals, Milwaukee, Wisconsin, USA) were added to the
dialysate so that final concentrations ranged from 1 to 20 tiM.
Dimethyl sulfoxide (DMSO) was used as a solvent for
cytochalasins at a final concentration of 0.1%. Dimethyl
sulfoxide alone (0.1%) did not affect permeability. Finally
following two washes, three recovery cycles were performed
using Ringer's solution alone.
Analytical techniques. In the middle of each 15-mm cycle a
50-pi blood sample was obtained from the tail vein in heparin-
ized capillary tubes for the determination of 3H-inulin and urea
concentration. Plasma (20 pi) was pipetted into an Aquasol
solution (New England Nuclear Corp., Boston, Massachusetts,
USA) and counted by a liquid scintillation counter (Mark
IV-Nuclear Chicago, Chicago, Illinois, USA). The plasma urea
concentration was determined from l0-d aliquots by the
method of Berthelot and Nessler [13], (Biodynamics Kit,
Boehringer Mannheim Biochemicals, Indianapolis, Indiana,
USA). 3H-inulin and urea were measured from 200-,td aliquots
of the peritoneal drainage obtained at the end of each cycle.
A micro-continuous gradient gel electrophoresis procedure
was used for the separation and quantitation of proteins in 1-pA
aliquots of the dialy sate at the end of each cycle. The continu-
ous gradient gels are contained in 5-pA microcaps. The analysis
is identical to that previously described for the analysis of urine
1141. In selected experiments the same method was used for the
analysis of plasma (diluted 1:51). Results are presented as
concentrations of total protein, albumin, high molecular weight
(HMW MW > albumin) and low molecular weight (LMW =
MW < albumin) fractions.
Systolic blood pressure was monitored during the course of
some experiments by the indirect tail-cuff method using a
pneumatic pulse transducer (Narco Biosystems), amplified and
recorded with a polygraph (Grass, model 79). This method gives
results comparable to direct intraarterial pressures [l4}.
Determination of peritoneal permeability. Because molecular
transfer across the peritoneum is thought to involve only
passive transfer processes, we have analyzed our data in a
fashion similar to that presented by Gosselin and Berndt [15]
assuming solutes move across the peritoneum exclusively by
diffusion. A more extensive development of the equations was
presented in a previous publication [41.
The quantity of 3H-inulin, urea or albumin transferred into
the peritoneal cavity per unit of time is given by a CdV/t. The
following equations therefore describe the net flux of solutes
across the peritoneal membrane.
. At
= C, — Cd
(1)
(2)
In the above equations, P equals the permeability of peritoneal
membrane, cmlmin; A, the effective peritoneal surface area
available for diffusion, an unknown parameter, cm2; iC, con-
centration gradient for urea, 3H-inulin or albumin; Cd and Ci,,
concentration of urea, 3H-inulin or albumin in dialysate or
plasma, respectively (mg/mi or cpm!ml); V, volume of dialysate
(25 or 30 ml); and t, time (15 mm).
This equation can be integrated to yield a term defining net
flux across the peritoneal membrane during each 15-mm clear-
ance period.
K[C — (Cd12)]t (3)
It can be seen that K, which equals P A, is in units of mllmin
and is in effect an expression for "clearance" in which backflux
of inulin, urea, and albumin from peritoneal cavity to blood is
considered. Application of Eq. (3) yielded more reproducible
and linear values for K from cycle to cycle than did the classical
expression for clearance, (VCd/t)/C, suggesting that backflux
may not be negligible during a 15-mm cycle. Each clearance
period was 15 mm, and at the end of the period, fluid in the
peritoneal cavity was removed and replaced by fresh dialysate.
Since there was a linear influx and a small backflux during the
short time frame of each clearance cycle, the product of C, —
Cd/2 (the average concentration gradient) times K, should yield
the rate at which probe molecules accumulate in the peritoneal
cavity, CdV/t.
Small increases in permeability to inulin (7%) and urea (16%)
occur after seven to nine consecutive cycles [4]. Where ap-
propriate, these time-dependent changes were used to correct
for clearances measured in these late cycles. One to eight
experiments were performed for each concentration of
intraperitoneal cytochalasins tested. The permeability derived
was expressed as the ratio of that measured in the same animal
during control cycles. Recovery was handled in a similar
manner. All results are presented as means SEM. The
Student's t test for paired observations was used to test for
significance.
Morphologic studies. The morphologic changes in omentum
induced by various concentrations of intraperitoneal cytochal-
asin were evaluated by thin-section electron microscopy (EM),
freeze fracture, and scanning electron microscopy (sEM). These
tissues were compared to those sampled from control and
recovery phases. Fixation was achieved by intraperitoneal
instillation of 2 ml of a 25% glutaraldehyde solution into the
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Table 1. Effect of cytochalasins on peritoneal permeability
Cytochalasins N
.Concentration
x l0 M
Inulin Urea
Kc, mi/mm KE/Kc KR/KcK, mi/mm KE/KC KR/Kc
CB 3 2 to 12 0.28 0.04 1.28 0.04 1.07 0.05 0.63 0.08 1.52 0.20 1.01 0.09
CB 6 20 0.25 0.02 1.29 0.12 1.06 0.16 0.68 0.08 1.61 0.15 1.23 0.12
CD 2 2 0.22 0.03 1.57 0.05 1.38 0.15 0.57 0.23 1.64 0.37 1.53 0.27
CE 2 2 0.15 0.03 1.59 0.00 1.77 0.02 0.45 0.02 1.29 0.04 1.62 0.31
Abbreviations: KR, permeability using tes t substance; Kc, permeability measured during control periods; KR, permeability measured during
recovery.
dialysate present in the peritoneal cavity at the end of the last
cycle. For freeze fracture, glutaraldehyde-fixed tissue was
passed through graded concentrations of glycerol up to 30% and
then frozen in Freon 22 and liquid nitrogen. Tissue was frac-
tured at — 100°C and shadowed with platinum and carbon in a
Denton FE-3 apparatus. For scanning EM, glutaraldehyde-
fixed tissue was critical-point dried in carbon dioxide (Sorvall
dryer), sputter-coated with gold at a 45° angle (Kinney SC-3
vacuum evaporator) and examined in a Jeol SEM (35CF). For
thin section transmission EM, tissue was postfixed in 1% 0504,
stained in block with a 0.5% uranyl acetate (pH = 5.1),
dehydrated in graded concentrations of ethanol, and embedded
in Epon. Freeze fracture and thin sections were examined in a
Siemens IA electronmicroscope. Tissues obtained at control
and recovery cycles were handled similarly. Morphological
studies were confined in omentum.
Results
Effects on urea and mu/in permeability. The effect of
cytochalasins on peritoneal permeability to small molecules
(urea) and medium size molecules (inulin) is presented in Table
1. Since the baseline (control) permeability varies from animal
to animal, permeability changes induced by cytochalasin are
expressed as the ratio of the experimental (KE) or recovery
(KR) permeability divided by the control value (Kc).
Cytochalasin B (CB) increased permeability to inulin 28% (P <
0.05). Greater increases (>50%) were observed with
cytochalasins D and E (CD and CE). These changes were
reversible at all concentrations of CB, but reversibility was less
with CD and CE. Changes in permeability to urea were more
pronounced (CB increased permeability to urea 52%, P < 0.05);
reversibility followed the same pattern as for inulin. There was
no significant change from control values in dialysate volume
during experimental and recovery cycles with CB, CD, or CE.
Absolute values for permeability revealed that the peritoneum
is about 2.5 times more permeable to urea than to inulin.
Effects on protein permeability. Peritoneal permeability to
protein did not increase significantly due to the dialysis proce-
dure using Ringers lactate dialysate. Dimethyl sulloxide at a
concentration of 0.1% was included in the dialysis fluid. The
average protein content for the control periods in all experi-
ments was comparable to that presented in Table 1 (total
protein = 21.5 2.0 mg!dl; albumin = 13.1 1.0 mgldl;
composition: HMW 33 2%, albumin = 73 2%, LMW
4 0.5%). A representative experiment is presented in Table 2.
Twelve consecutive 15-mm dialysis cycles were performed and
the concentrations of total protein and albumin and the frac-
tional composition of protein were measured. There was no
Table 2. Effect of dialysis and time on protein content of dialysate°
Periodb
.Total protein
mg/dl
.Albumin
mg/dl
HMW Albumin LMW
%
1 24.2 2.8 15.9 1.6 28 4 69 6 3 I
2 28.5 0.6 18.8 0.6 28 3 69 3 2 0.4
3 25.3 0.6 16.7 0.4 29 1 69 0.4 2 1
4 23.8±2.1 16.1±1.0 25±2 71±4 4±3
Abbreviations: HMW, high molecular weight; LMW, low molecular
weight.
a No significant differences are seen.
b Each period represents the average SE of three 15-mm cycles.
significant change in peritoneal permeability to these proteins
with time (180 mm).
Cytochalasin B was found to increase the concentration of
albumin in the dialysate in a dose-dependent fashion (Fig. 1).
The peak albumin concentration was plotted on the vertical axis
as percentage increment over the mean control concentration.
These effects were reversible as shown in Figure 2. Note that
the CB-induced protein leakage into the peritoneal cavity is
non-selective with respect to molecular weight.
In experiments where plasma protein was measured we
calculated a permeability to albumin (Kbumjfl) (Table 3). Perme-
ability changes are again presented as the ratio of maximum
permeability measured during the experimental period or the
minimum value measured during the recovery cycle relative to
that averaged in control cycles. The ratio of dialysate to plasma
albumin concentration (Cd/Cr) is analogous to the sieving
coefficient across the glomerular membranes. The control value
of 53 x i0 is fifteen times greater than that measured in the
normal rat kidney [161. This leak of protein across the pen-
toneal membranes leads to significant protein loss during the
entire procedure. The average total protein loss during
cytochalasin B (20 x 106 M) experiments was equal to 12% of
the calculated plasma protein pool [product of plasma volume
[17] and plasma protein concentration (Table 3)1. The rate of
protein loss (mg124 hr x 100 g of body wt) was comparable to
that seen in nephrotic animals (200 to 400 mg!24 hr) and far in
excess of the normal protein excretion rate by the kidney (5
mg/24 hr x 100 g of body wt) [161.
Table 3 also includes values for plasma protein and albumin
concentration, hematocrit, and blood pressure. These measure-
ments show only moderate changes during the nine dialysis
cycles and therefore attest to the physiological stability of the
animal. The reversal of the permeability ratio to 1.3 is consist
ent with the drop in dialysate protein concentration during the
recovery cycles (Fig. 2).
Although not shown in Table 3, both cytochalasins E and D
caused greater changes in protein permeability than cytochal-
asin B and their effects were not completely reversible during
the time course of the recovery period. CD, at a concentration
of 2 x 10-6 M, induced a sixfold increase in total protein and
albumin compared to the control value. In addition, red blood
cells were observed in the dialysate after administration of
cytochalasin D.
The fractional contribution of albumin and HMW and LMW
proteins to dialysate total protein is presented in Figure 3. The
control dialysate pattern is contrasted with that seen during the
peak response to cytochalasin. The fractional composition of
plasma protein samples during the peak response cycle is also
included. Albumin accounted for over 60% of total protein in
the dialysate in control periods. Dialysate composition under
both conditions was significantly different from that of plasma
(P < 0.005). However, cytochalasins E and D abolished this
selectivity and the protein pattern resembled more closely that
of plasma. This was consistent with the more potent effect of
these cytochalasins noted above. Administration of cytochal-
asin B did not change fractional composition significantly.
Electrophoresis scans of dialysis fluid and diluted plasma
(1:51) from a representative experiment after the administration
of cytochalasin B (20 x 10_6 M) are presented in Figure 4.
Cytochalasin B increases protein movement into the peritoneal
cavity quantitatively without altering relative composition, sug-
gesting that more pores are opened rather than existing pores
are enlarged.
Discussion
Recently, evidence supports the participation of cytoskeletal
elements in the control of paracellular permeability in epithelial
membranes [5, 6]. The data presented in this paper represent
the first attempt to alter permeability in peritoneal dialysis by
use of agents that disrupt the microfilament system. The evi-
dence that cytochalasins augment peritoneal permeabilities
confirm and extend the previous observations of Glinsukon et al
[7], Hayakawa et al [81, and Glinsukon, Shank, and Wogan [9].
Investigating the toxicology of cytochalasins D and E, these
investigators reported that animals receiving a lethal dose
intravenously developed rapid exudation of plasma proteins
into pleural and pentoneal cavities, and death from shock
within 2 to 19 hr. These investigators further concluded that the
effects were most likely due to the drug acting directly on the
capillary walls. The lethal doses at which these effects were
observed was 10 mg/kg with cytochalasin D for Swiss mice and
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Morphological changes induced by cytochalasins. By thin
section EM (Fig. 5) structural changes in the mesothelial cell
were quite subtle and consisted of some thickening and clump-
ing of microfilaments in submembranous regions and adjacent
to tight junctions. However, in focal regions, zeiotic evagina-
tion of the apical membrane was observed and in these regions,
submembranous microfilaments were fragmented and their ori-
entation within microvilli and in submembranous regions was
obviously disrupted. In most microvilli integrity of the
microfilamentous core was largely preserved. On scanning
electronmicrographs, it is apparent that this increase in
microvilous growth is very extensive (Fig. 6 A and B). Protru-
sions of the apical surface appear more as a web rather than as
true microvilli. When exposed to cytochalasin B (20 x 106 M),
these apical membrane protuberances become much more
prominent, both with respect to their length and thickness.
These membrane protuberances herniate from the apical cell
surface and are probably identical to a "zeiotic knob" noted in
thin section electronmicrographs (Fig. 5).
When cytochalasin B was removed and peritoneal mem-
branes were allowed to recover (30 mm, 2 and 24 hr), a return
to normal configuration of the mesothelial cell apical surface
was apparent although incomplete (Fig. 7 A and B). On scan-
ning electron microscopy, the effect of cytochalasins D and E
5 10 15 20 25 on formation of zeiotic knobs was more pronounced than with
cytochalasin B.
Tight junctions did not appear disrupted by cytochalasin B
exposure (Fig. 5). Even in freeze fracture replicas, no major
differences were seen in the tight junctional intramembranous
structure of mesothelial cells when control was compared to
cytochalasin B (Fig. 8 A compared to B). Irregularities in the
strand meshwork were seen more frequently after cytochalasin
B exposure, but this could reflect differences in tissue process-
ing [18]. However, the frequency of an expansive fracture
through mesothelial cell membranes was so low that a
morphometric analysis of tight junctional structure was
impractical.
Capillaries within the fabric of the omentum did not reveal
gross abnormalities either in thin section or freeze fracture
electronmicrographs. The most obvious changes as described
above were in the apical membrane of mesothelial cells.
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Control Cytochalasin B Recovery
Kbumin,
mI/mm 0.008 0.001 0.020 0.002 0.010 0.001
K/Kontroi 1.0 2.5 0.2 1.3 0.1
(Cd/Cp)aibumin,
x 1O 53 5 114 11 62 4
Plasma pro-
tein, gIdi 6.3 0.3 6.1 0.4 5.7 0.3
Plasma albu-
min,g/dl 2.8 0.1 2.5
Hematocrit, % 45 1 46 1 47 2
Systolic blood
pressure,
mmHg 119 103 6 95
a Values are means SE; the number of animals is five. Cytochalasin
B was added to the dialysate at a concentration of 20 x l0_6 M.
2.6 mg/kg and 4.6 mg/kg for mice and rats, respectively, with
cytochalasin E [7—91.
Cytochalasins are fungal products that alter cell morphology.
Cytochalasin B binds to the growing end of filamentous actin,
causes depolymerization [191, and changes in microfilament
assembly which lead to alteration in motility-related processes
such as locomotion and cytokinesis [11, 12, 19]. Zeiosis, in
which there is focal budding of the cell membrane, is presum-
ably due to loss of cytoskeletal anchoring of the cell membrane.
Another biologic effect of cytochalasin B is alteration of trans-
port across the plasma membrane. Cytochalasin B is one of the
most potent competitive inhibitors of hexose and nucleoside
transport [10, 20, 211. The effect is mediated by cytochalasin B
binding to some part of the glucose transport carrier [221.
Cytochalasins D and E do not bind to the glucose carrier protein
and therefore do not have the transport inhibitory effect [10,
22]. Exactly which of these biological actions is responsible for
the increase in permeability of the peritoneum is uncertain. In
this study cytochalasins were exposed to the outside surface of
the peritoneum. Since cytochalasins may have a limited perme-
B
Control CB, 12X 106M Recovery
6 7 8 1 2 3 4 5 6 7 8
ability across cell membranes, access to the capillary endo-
thelium may be hindered and perhaps limited to capillaries not
covered by mesothelial cells. The roles played by the various
membranes that constitute the peritoneum in the control of
diffusion of molecules of different size, charge, and shape
remain poorly understood. In the omentum, a single layer of
mesothelial cells rests on a collagenous matrix containing
capillaries, lymphatics, elastic fibers, histocytes, and fibrocytes
[24—26]. Omentum not encircling the gut, consists of two
diametrically apposed mesothelial cell layers in a sandwich type
array on each side of the matrix. Microvilli-like projections 0.1
m in length are present on the apical surface of the mesothelial
cells. These microvilli and the adjacent cytoplasmic regions
have a cytoskeletal architecture not too dissimilar to that in
resorptive epithelia [27]. In addition, in the subdiaphragmatic
areas, mesothelium is discontinuous, leading to the formation of
"lacunae" or pores 4 to 12 m in diameter [28]. In these regions
capillaries would presumably be in intimate contact with the
peritoneal cavity.
Several mechanisms exist to explain solute transport across
the peritoneum: diffusion and ultrafiltration dependent on con-
centration and pressure (osmotic and hydrostatic) gradients,
and pinocytotic transport through mesothelial and endothelial
cells [26]. Which membranes are rate-limiting barriers for solute
transport remains unclear. The barriers include: (1) the capil-
lary wall and its basement membrane, (2) the unstirred intersti-
tial fluid, and (3) the mesothelium. The mesothelium contains
both transcellular and paracellular pathways. For small water-
soluble molecules such as urea, transcellular diffusion across
the capillary and mesothelial cells plus the interstitium is
undoubtedly the most important pathway, particularly when a
relative effective area for diffusion (transcellular vs. paracel-
lular) is considered. For larger or ionized molecules, evidence
supports the paracellular pathway as being the major final path
for transport [29]. For example, passage of horseradish per-
oxidase (molecular weight, 40,000 daltons) through tight junc-
tions of rat mesothelium has been demonstrated [30]. Neverthe-
less, even though tight junctions of mesothelial cells may be
A
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Fig. 2. Changes in dialysate protein
concentration during administration of
cytochalasin B. Symbols are: •, total protein;
A, albumin; , high molecular weight.
Table 3. Effect of cytochalasin B on albumin permeability, plasma
composition, and blood pressure
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X106M
Fig. 3. Fractional protein composition of
dialysate and plasma. Numbers in
parentheses denote the number of animals.
Data are given where appropriate as the
mean SEM. Symbols are: I, high
molecular weight; i1, albumin; U, low
molecular weight.
Control
Dialysate Plasma
Cytochalasin-B
Fig. 4. Electrophoretic analysis of plasma and
dialysate. The direction of migration is from
left to right. The arrows indicate the albumin
band in the densitometer scan. The sample
volume is 1 1d.
relatively "leaky," these structures may still be the rate-
limiting barrier for medium-sized molecules such as inulin [27].
For many proteins, the transcellular pinocytic pathway may
also be important [261. In addition, it is more likely that the
lacunal region, where the capillary endothlium is in direct
contact with peritoneal fluid, is the major site of protein flux
into the peritoneal cavity.
Physiologic studies using dextrans (molecular weight, 10,000
to 90,000) have described the peritoneal membrane as a mosaic
of small and large "pores" [1]. While "pores" having an
effective radius of 15 to 20 A constitute the major pore area,
another population of "pores" with an effective radius of 70 A
constitutes 0.01% of the total "pore" surface area. Perhaps the
subdiaphragmatic lacunae represents the 70 A "pores" in these
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Fig. 5. Electron micrograph of omentum after exposure to cytochalasin
B. Note zeiotic protuberances in the apical membrane of this
mesothelial cell designated by the arrows. Microfilaments in these
regions are no longer filamentous but appear as fragments.
Microtubules and mitochondria appear normal. (x 40,000) An intact
tight junction (TJ) from the same mesothelium is shown in the insert.
(x66,000)
studies. The fact that cytochalasin B reversibly increased
permeability to protein suggests that a major effect was on the
population of subdiaphragmatic capillaries. Since selectivity of
protein diffusion remained unchanged with cytochalasin B (Fig.
4), it would appear that there was an increase in the number of
lacunae or alternatively more capillary pores were made avail-
able for diffusion. In contrast the loss of selectivity with
cytochalasins D and E and lack of recovery suggest an irrevers-
ible increase in pore diameter.
Cytochalasins when administered intravenously can indeed
increase local blood flow [31, 32]. Natori [33] has measured the
"irritative toxicity" of these drugs by intradermal injections at
concentrations of 20 to 200 tM. Since considerable local
inflammatory responses developed in the injected areas, in-
creased peritoneal blood flow may explain some of the effect on
permeability reported in this paper. This mechanism remains
open to future exploration. We do not believe that alterations in
blood flow can explain all the effects since differential effects on
permeability were clearly evident. Pentoneal clearance is rela-
tively insensitive to variation in mesenteric blood flow [341.
Aune [35] observed that peritoneal blood flow has to drop by
80% before any change in peritoneal clearance is observed.
Fig. 6. Scanning electron micrograph of omentum. A Control. B 45-mm
exposure to 20 x 10-6 M cytochalasin B, Note the extensive extrusion
of cytoplasm (zeiosis). (x 6000)
Zeiotic knobs form as the result of displacement and detach-
ment of the cortical submembranous microfilaments which form
a continuous barrier between the endoplasm and inner face of
the plasma membrane [36]. Cytochalasin B enhances cell con-
traction. This allows displacement of the microfilament web and
herniation of endoplasmic component of the cytoplasm follows.
Cells of epithelial origin show zeiotic knobs more readily.
Although omentum is mesothelial in origin, it showed marked
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Fig. 7. Scanning electron micrograph of omentum. A Two and one-half
hours after GB removal. Zeiotic knobs are less frequent but still
present. B Twenty-four hours after GB removal. Note the return to the
control condition. (x 6000)
zeiosis when exposed to cytochalasins. Zeiotic knobs were not
rapidly reversible as reported for epithelial cells.
Since a major effect of cytochalasins is on the cell surface
membrane, it is likely that these drugs would alter the transcel-
lular pathway rather than the paracellular. Since urea can pass
both transcellularly and paracellularly, any possible perturba-
tion of tight junction permeability with its small area relative to
Fig. 8. Intramembranous structure of mesothelial cell tight junctional
region from the omentum as revealed by freeze fracture electronmicro-
scopy. A Gontrol. (x 68,000) B After exposure to cytochalasin B (20 X10 si) dissolved in peritoneal fluid 30 mm prior to fixation. The
peritoneal cavity is indicated by cellular projections labeled MV. Gap
junctions (GJ) are frequently observed in tight junctional regions of the
plasma membrane. (X 68,000)
that of the mesothelial cell, is unlikely to lead to substantial
changes in permeability to urea. However, permeability to
inulin which probably passes only paracellularly would be more
affected if there was any alteration in tight junctional perme-
ability induced by cytochalasin B [5, 6]. Inulin permeability
changed to a lesser degree than urea with cytochalasin B, which
is consistent with the absence of gross alterations in tight
junctions (Figs. 5 and 8).
We propose that cytochalasin B effects on intraperitoneal
protein flux were predominantly due to alterations in capillary
permeability. CB (20 x 10—6 M) had its greatest effect on
permeability to protein: KEIKC for inulin was 1.29; urea, 1.61;
and albumin, 2.50. A clear dose-response relationship is evident
(Fig. 1).
The potential use of agents active on cytoskeletal function in
reversibly altering peritoneal permeability during dialysis de-
serves further exploration. Such agents may serve as tools in
advancing our understanding of barriers to peritoneal transport.
Most importantly, we have utilized these compounds to in-
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dicate that the peritoneal membrane consists of at least three
rate-limiting barriers, each of which has its own size selectivity.
Perhaps these barriers can be therapeutically manipulated to
augment clearance of specific types of molecules. Our data
show that cytochalasin B is a potent compound in augmenting
peritoneal permeabilities and that its effects are partially revers-
ible. The structure activity relationships and the therapeutic
role of potentially less toxic cytochalasin derivatives in altering
permeability remain an area for future exploration.
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